Xceed Molecular

Microarrays, genomics, fluidics

Metrigenix, renamed to Xceed Molecular in 2006, is a spin-off from Gene Logic and was established in 2001. Gene Logic still owns 54% of the company and markets the Flow-thru Chip both as custom and pre-fabricated gene-based screening array.

Investors of the new company include Oxford Bioscience Partners, Burrill Biotechnology Capital Fund, Infineon Ventures and GE Capital Equity.

1 Marmac Drive
Toronto, Ontario M9W 1E7
Canada
Phone: +1-416-798-1625
Fax: +1-416-798-8635